According to the latest report by IMARC Group “Aortic Valve Replacement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global aortic valve replacement market size reached US$ 8.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 15.8 Billion by 2027, exhibiting a growth rate (CAGR) of 11.59% during 2022-2027.
Aortic valve replacement refers to the procedure of replacing a non-functioning valve with an artificial heart valve. Aortic valves are one of the four valves that control the flow of blood through the heart. It separates the left ventricle and the main artery, which supplies oxygen-rich blood to the aorta. Improper functioning of the aortic valve interferes with the blood flow and forces the heart to work harder. Aortic valve replacement restores normal blood flow, reduces the symptoms, prolongs life, and preserves the proper function of the heart muscle. The replacement process is performed with prosthetic and artificial valves made from synthetic materials or animal tissues such as pig, cow, and human donors.
Request for a free sample copy of this report: https://www.imarcgroup.com/aortic-valve-replacement-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The global aortic valve replacement market is primarily driven by increasing valvular diseases such as aortic stenosis and aortic regurgitation. The rising geriatric population has also increased the demand for aortic valve replacement methods as valves become narrow and stiff from aging. Besides this, governments ofdifferent countries are undertaking initiatives to create awareness about valve replacement surgeries and providing high reimbursement rates to patients. For instance, the European Association of Percutaneous Cardiovascular Interventions has launched The Valve for Life Initiative to improve access to aortic valve replacement across Europe. Furthermore, technological advancements in replacement surgeries and minimally invasive (MI) techniques are significantly fueling the market growth.
Breakup by Surgery:
- Open Surgery
- Minimally Invasive Surgery
Breakup by Product:
- Transcatheter Aortic Valve
- Sutureless Valve
Breakup by End Use:
- Ambulatory Surgery Centers
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Anteris Technologies Ltd.
- Boston Scientific Corporation
- Coroneo Inc.
- CryoLife Inc.
- Edward Lifesciences Corporation
- JenaValve Technology Inc.
- LifeNet Health Inc.
- LivaNova PLC
- Medtronic plc
- Thubrikar Aortic Valve Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/aortic-valve-replacement-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800